ThromboGenics reported a net loss of €37.9 million, or €1.05 per share, in 2015 compared with €51.1 million, or €1.42 per share, in 2014, according to a company press release. Total revenue was reported at €11.2 million in 2015, which included €7.4 million in Jetrea sales in the U.S. and €3.2 million in royalties from Alcon based on sales of Jetrea outside the U.S.
The Japanese Ministry of Health, Labor and Welfare has approved the iStent trabecular micro-bypass stent for use in conjunction with cataract surgery to lower IOP in patients with mild to moderate open-angle glaucoma, according to a press release from Glaukos. “We appreciate the efforts of the MHLW to evaluate and approve the iStent, and we are eager to introduce this breakthrough MIGS technology to Japanese surgeons and patients,” Thomas Burns, president and CEO of Glaukos, said in the release.
A new UCLA psychology study provides insights into how the brain combines sound and vision.
In this video, Grazia Pertile, MD, head of the Ophthalmology Department of Negrar Hospital, Italy, presents her personal technique of autologous choroidal transplantation, a surgical procedure that may benefit selected cases of advanced age-related macular degeneration that do not respond to anti-VEGF treatment.“We cannot transplant the retina but can replace the damaged layer under the retina with a healthy patch of choroid, providing a healthier substrate to nourish the retina,” Pertile said.
San Marino, one of the world’s smallest countries, recently introduced revolutionary changes in the way eye care is organized and delivered, adopting a technologically updated, patient-centered, integrated approach to services.The leader of this project, Alessandro Mularoni, MD, was appointed head of ophthalmology in June 2015, with carte blanche for introducing innovation.
The Boston keratoprosthesis type 1 can produce significant visual recovery in eyes with debilitating corneal surface disease, but the amount of recovery may be associated with type of pathology, according to a study.In a multicenter, prospective study …